IRTC (iRhythm Technologies) COGS-to-Revenue : 0.31 (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is iRhythm Technologies COGS-to-Revenue?

iRhythm Technologies's Cost of Goods Sold for the three months ended in Mar. 2025 was $49.5 Mil. Its Revenue for the three months ended in Mar. 2025 was $158.7 Mil.

iRhythm Technologies's COGS to Revenue for the three months ended in Mar. 2025 was 0.31.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. iRhythm Technologies's Gross Margin % for the three months ended in Mar. 2025 was 68.83%.

iRhythm Technologies COGS-to-Revenue Historical Data

The historical data trend for iRhythm Technologies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies COGS-to-Revenue Chart

iRhythm Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.27

0.34

0.31

0.33

0.31

iRhythm Technologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.34	0.30	0.31	0.30	0.31

iRhythm Technologies COGS-to-Revenue Calculation

iRhythm Technologies's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	184.308	/	591.839
	=	0.31

iRhythm Technologies's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	49.461	/	158.677
	=	0.31

iRhythm Technologies (NAS:IRTC) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

iRhythm Technologies's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	49.461 / 158.677
	=	68.83 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

iRhythm Technologies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of iRhythm Technologies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

iRhythm Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (NAS:IRTC) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

0A7L:UK I25:Germany

Address

699 8th Street, Suite 600, San Francisco, CA, USA, 94103

Website

https://www.irhythmtech.com

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Executives

Minang Turakhia	officer: EVP, CMO & CSO	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Daniel G. Wilson	officer: EVP, Strategy Corp Dev Inv Rel	699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103
Quentin S. Blackford	director, officer: President and CEO	7475 LUSK BLVD., SAN DIEGO CA 92121
Patrick Michael Murphy	officer: CLO & EVP RA/QA MrktAcs & Gov	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Sumi Shrishrimal	officer: EVP, Chief Risk Officer	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Chad Patterson	officer: Chief Commercial Officer	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Abhijit Y Talwalkar	director	ONE AMD PLACE, PO BOX 3453, SUNNYVALE CA 94088
Brice Bobzien	officer: Chief Financial Officer	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Mervin Smith	officer: EVP Strategic Business Ops	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Marc W. Rosenbaum	officer: Chief Accounting Officer	7475 LUSK BLVD., SAN DIEGO CA 92121
Mark J. Day	officer: EVP, Research & Development	C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 500, SAN FRANCISCO CA 94103
Brian B Yoor	director	100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064
Mojdeh Poul	director	3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST PAUL MN 55144-1000
Douglas Devine	officer: Chief Financial Officer	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103
Bairey Merz Cathleen Noel	director	16664 CUMBRE VERDE COURT, PACIFIC PALISADES CA 90272